cefuroxime + piperacillin-tazobactam

Cefuroxime + piperacillin-tazobactam is a combination of two broad-spectrum beta-lactam antibiotics, sometimes used together as empirical therapy for severe bacterial infections. Cefuroxime is a second-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Piperacillin is an extended-spectrum ureidopenicillin that also targets PBPs, while tazobactam is a beta-lactamase inhibitor that protects piperacillin from enzymatic degradation by beta-lactamase-producing bacteria. This combination may be considered in clinical settings where mixed or resistant organisms are suspected, such as in severe hospital-acquired infections or bacteremia[1][2][8]. The use of both agents together aims to broaden antibacterial coverage and address potential resistance mechanisms.